HCK

aview: LCS

AI for Lung Nodule Detection and Analysis

All products
HCK

Radiology

HCK

Lung Cancer Screening

An AI Solution for Detection and Analysis of Lung Nodules from Chest CT.

 

Conformity Certifications

MFDS

Republic of Korea

FDA

USA

PMDA

Japan

TFDA

TaIwan

CE

Europe

TGA

Australia

HSA

Singapore

ANVISA

Brazil

HC

Canada

 

Automated Nodule Detection and Lung-RADS Calculation

Detecting and Analyzing Easy to miss Lung Nodules on Low-Dose Chest CT with Imaging Artificial Intelligence.

Efficiently diagnose with awareness of patient conditions.

Finding microscopic nodules provides a variety of information, including basic, number of nodules, size and status, and RADS category. Findings that are likely to develop into lung cancer can also be checked in advance, reducing working time and allowing efficient reading depending on the case. Microscopic Nodule Detection: Providing Comprehensive Information on Number of Nodules, Size, Status, and RADS Category Early Detection of Potential Lung Cancer Development Enables Time-efficient Scans Reading.

HCK

Detecting Nodules of Various Sizes, from Small to Large

HCK
 

Follow up mode

Automated Matching of Follow-up with Previous Lung CT Scans Instantly Assess Nodule Changes.

Monitoring Nodule Growth is Vital for Accurate Readings.

It autonomously assesses growth and changes by matching lung nodules, going beyond mere image comparisons.aview LCS efficiently classifies lung nodules into the relevant categories according to the Lung CT Screening Reporting and Data System (Lung-RADS ver 1.1) guidelines as recommended by the American College of Radiology.

HCK
 

Clinical Viewer

CT Findings are visualized in 3D.
User-Friendly Viewer for Medical Professionals and Patients.


Advanced 3D Rendering of Patient’s Lung.

2D Images May Not Provide Adequate Information of Abnormal Findings Visualized 3D Model of Patient’s Lung is much more informative and intuitive. Abnormal findings can be easily explained by demonstration of the 3D Model.

HCK
 

Delivering Comprehensive Analysis Results

Automatically Analyze Lung Cancer Screening Results and Generate Comprehensive Reports.

Automate Tedious manual Tasks to Save Time.

HCK
 

Validations

Clinically Proven: AI Medical Technology Saves Time and Enhances Reading Accuracy.

1
HCK

-70%

Time Saving

2
HCK

+34%

Sensitivity

3
HCK

-42%

False positivity rate

4
HCK

-86.7%

Reduce Workload

  • 123https://dailybulletin.rsna.org/db22/index.cfm?pg=22fri07
  • 4Lancaster HL, Zheng S, Aleshina OO, Yu D, Yu Chernina V, Heuvelmans MA, de Bock GH, Dorrius MD, Willem Gratama J, Morozov SP, Gombolevskiy VA, Silva M, Yi J, Oudkerk M. Outstanding negative prediction performance of solid pulmonary nodule volume AI for ultra-LDCT baseline lung cancer screening risk stratification. Lung Cancer. 2022 Jan 6;165:133-140
 

References:

HCK

Outstanding negative prediction performance of solid pulmonary nodule volume AI for ultra-LDCT baseline lung cancer screening risk stratification

HCK

Feasibility of implementing a national lung cancer screening program: Interim results from the Korean Lung Cancer Screening Project (K-LUCAS)

 
Related products
HCK

RBhip™

Analysing Hip Dysplasia and Impingement on...

Marked
HCK

Curemetrix Suite

Triage and assistance diagnosis of breast ...

Pending
HCK

LungCT AI

Nodules detection in chest CT

Marked